List of Studies ( Metabolite:Eicosadienoyl-EA)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004300 | AN007152 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Brain | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004300 | AN007152 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Liver | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004300 | AN007154 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Brain | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004300 | AN007154 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Liver | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004153 | AN006894 | Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model | Feces | Rat | Shanghai Jiao Tong University | LC-MS | |
| ST003362 | AN005504 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST003362 | AN005506 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003239 | AN005305 | Lipidomic analysis of adipose from Gclc WT and whole-body Gclc KO mice. | Adipose tissue | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003238 | AN005303 | Lipidomic analysis of serum from Gclc WT and whole-body Gclc KO mice. | Blood | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003053 | AN005006 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | LC-MS |
| ST003044 | AN004994 | A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics | Blood | Human | Obesity | University of Colorado Denver | LC-MS |
| ST003038 | AN004984 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Liver | Mouse | Diabetes | Vanderbilt University Medical Center | LC-MS |
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002844 | AN004658 | Identification of fatty acids which form triglycerides in TgLC mouse serum | Blood | Mouse | Cancer | Rutgers University | LC-MS |
| ST002191 | AN003586 | Amelioration of developmental programming of NAFLD in fetal liver using PQQ | Liver | Mouse | Fatty liver disease | University of Oklahoma Health Sciences Center | LC-MS |
| ST002182 | AN003574 | Amelioration of developmental programming of NAFLD in weanling liver using PQQ | Liver | Mouse | Fatty liver disease | University of Oklahoma Health Sciences Center | LC-MS |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mouse | Diabetes | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001795 | AN002915 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | LC-MS | |
| ST001680 | AN002740 | Metabolome of NAFLD in high fat diet mouse model | Liver | Mouse | Fatty liver disease | Weill Cornell Medicine | LC-MS |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST000551 | AN000842 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Muscle | Mouse | Diabetes | Mayo Clinic | LC-MS |
| ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash University | LC-MS | |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences | LC-MS | |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
